öλÔÓéÀֵǼÈë¿ÚÏÂÔØ

µ¼Ê¦ÐÕÃû£ºÍôÄÏƽ
ÐÔ±ð£º
ÈËÆøÖ¸Êý£º105

ËùÊôԺУ£º´óÁ¬Ò½¿Æ´óѧ
ËùÊôԺϵ£ºÒ½Ñ§¿ÆѧÑо¿Ôº
Ö°³Æ£º½ÌÊÚ
µ¼Ê¦ÀàÐÍ£º²©µ¼
ÕÐÉúöλÔÓéÀֵǼÈë¿ÚÏÂÔØ£º
Ñо¿ÁìÓò£º 1£®ÐÄѪ¹Ü²¡£º¶¯ÂöÖàÑùÓ²»¯¼°Ñª¹ÜÔÙÏÁÕ­·Ö×Ó²¡Àí»úÖÆÑо¿£»2£®ÌÇÄò²¡·ÀÖΣºÌÇÄò²¡Ñª¹Ü²¡±äµÄ·Ö... [Õ¹¿ª]


Ñо¿ÁìÓò£º 1£®ÐÄѪ¹Ü²¡£º¶¯ÂöÖàÑùÓ²»¯¼°Ñª¹ÜÔÙÏÁÕ­·Ö×Ó²¡Àí»úÖÆÑо¿£»2£®ÌÇÄò²¡·ÀÖΣºÌÇÄò²¡Ñª¹Ü²¡±äµÄ·Ö×Ó»úÖÆÑо¿£»3£®ÊÜÌåÓë»ùÒò±í´ïµÄµ÷¿Ø£ºÑª¹Ü·Ö×Ó»úе¡ª¡ªÉúÎïÐźÅתµ¼Ñо¿¡£ [ÊÕÆð]




ͨѶ·½Ê½ :
°ì¹«µç»°£º**
µç×ÓÓʼþ£ºmoneylei2015@163.com


¸öÈ˼òÊö :
ÍôÄÏƽ½ÌÊÚ£¬²©Ê¿Éúµ¼Ê¦£¬´óÁ¬Ò½¿Æ´óѧҽѧ¿ÆѧÑо¿Ôº¸±Ôº³¤¡¢ÌØƸ½ÌÊÚ¡£±±¾©Ò½¿Æ´óѧ£¨ÏÖΪ±±¾©´óѧҽѧ²¿£©Ò½Ñ§²©Ê¿£¬ÔøÈÎÃÀ¹ú¼ÓÖÝ´óѧʥµØÑǸç·ÖУÉúÎ﹤³ÌϵÑо¿ÖúÀí½ÌÊÚ£¬±±¾©´óѧÐÄѪ¹ÜÑо¿Ëù½ÌÊÚ£¬Î÷°²½»Í¨´óѧҽѧԺÌØƸ½ÌÊÚ¡£³¤ÆÚÑо¿¹ÚÐIJ¡¡¢¸ßѪѹ¡¢ÌÇÄò²¡¡¢Ö¬·¾¸ÎµÈÐÄѪ¹Ü¼°´úл¼²²¡µÄ·¢²¡»úÖƺͷÀÖη½·¨ÒÔ¼°»úÌåÄÜÁ¿´úлµ÷½ÚµÄ·Ö×Ó»úÀí¡£Ñо¿³É¹û·¢±íÔÚCirculation¡¢Hepatology¡¢PNASµÈ¹ú¼ÊÖøÃûÆÚ¿¯¡£Ö÷³Ö¹ú¼Ò×ÔÈ»¿Æѧ»ù½ðίÖØ´óÏîÄ¿¡¢ÖصãÏîÄ¿¡¢ÖØ´ó¹ú¼ÊºÏ×÷ÏîÄ¿µÈ¶àÏî¹ú¼Ò¼¶¿ÆÑÐÏîÄ¿¡£¼æÈιú¼Ò×ÔÈ»¿Æѧ»ù½ðίԱ»áҽѧ¿Æѧ²¿×¨¼Ò×ÉѯίԱ»áίԱ£¬ÑÇÖÞѪ¹ÜÉúÎïѧ»áÃØÊ鳤£¬ÈÕ±¾Ñ­»·Ñ§»áÔÓÖ¾¡¢PPAR Research¡¢ÁøÒ¶µ¶ÖÐÎÄ°æµÈ¶àÖÖѧÊõÆÚ¿¯µÄ¸±Ö÷±àºÍ±àί£¬ÊÇÎÒ¹úÐÄѪ¹Ü¼°´úлÑо¿ÁìÓòµÄÖøÃûר¼Ò¡£ÅàÑøµÄÑо¿Éú¶àÈ˴λñµÃ±±¾©´óѧÓÅÐãÂÛÎĽ±¡£

¿ÆÑй¤×÷ :
ÔÚÑÐÏîÄ¿£º1.¹ú¼Ò×ÔÈ»¿Æѧ»ù½ðÖØ´ó¹ú¼Ê£¨µØÇø£©ºÏ×÷Óë½»Á÷ÏîÄ¿£¬¡°ÑªÁ÷¼ôÓ¦Á¦¶ÔѪ¹ÜÄÚƤϸ°û½â¶¾×÷Óõĵ÷½Ú»úÖÆ¡±£¬ÏîÄ¿¸ºÔðÈË£»2.¹ú¼Ò×ÔÈ»¿Æѧ»ù½ðÖصãÏîÄ¿£¬¡°Ö¬·¾Óë¾ÞÊÉϸ°û¼äÏ໥×÷ÓÃÓëÒȵºËصֿ¹µÄ»úÖÆ¡±£¬ÏîÄ¿¸ºÔðÈË£»3.¹ú¼Ò×ÔÈ»¿Æѧ»ù½ðÃæÉÏÏîÄ¿£¬¡°àçßòÍé¶þͪÓÕµ¼ÐÄÔàÖع¹µÄ·Ö×Ó»úÖÆ¡±£¬ÏîÄ¿¸ºÔðÈË¡£
´ú±íÐÔÎÄÕ£º
1. Fang X, Stroud MJ, Ouyang K, Fang L, Zhang J, Dalton ND, Gu Y, Wu T, Peterson KL, Huang HD, Chen J, Wang N*. Adipocyte-specific loss of PPAR¦Ã attenuates cardiac hypertrophy. JCI Insight. 2016 Oct 61(16):e89908.
2. Yin R, Fang L, Li Y, Xue P, Li Y, Guan Y, Chang Y, Chen C, Wang N*. Pro-inflammatory Macrophages suppress PPAR¦Ã activity in Adipocytes via S-nitrosylation. Free Radic Biol Med. 201589: 895-905.
3. Wang X, Fang X, Zhou J, Chen Z, Zhao B, Xiao L, Liu A, Li YS, Shyy JY, Guan Y, Chien S, Wang N*. Shear stress activation of nuclear receptor PXR in endothelial detoxification. Proc Natl Acad Sci USA. **:13174-9.
4. Liu Y, Tian XY, Mao G, Fang X, Fung ML, Shyy JY, Huang Y, Wang N*. Peroxisome proliferator-activated receptor-¦Ã ameliorates pulmonary arterial hypertension by inhibiting 5-hydroxytryptamine 2B receptor. Hypertension. 201260(6):1471-8.
5. Tian J, Wong WK, Tian XY, Zhang P, Huang Y, Wang N*. Rosiglitazone attenuates endothelin-1-induced vasoconstriction by upregulating endothelial expression of endothelin B receptor. Hypertension. 201056:129-35.